Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
19.79
-0.45 (-2.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
Viridian Therapeutics Employees
Viridian Therapeutics had 94 employees as of December 31, 2023. The number of employees increased by 8 or 9.30% compared to the previous year.
Employees
94
Change (1Y)
8
Growth (1Y)
9.30%
Revenue / Employee
$3,213
Profits / Employee
-$2,734,936
Market Cap
1.57B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teladoc Health | 5,600 |
Certara | 1,391 |
10x Genomics | 1,259 |
InMode | 581 |
Immunocore Holdings | 497 |
Arvinas | 445 |
Dynavax Technologies | 408 |
Travere Therapeutics | 380 |
VRDN News
- 9 days ago - Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data - Business Wire
- 15 days ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Viridian Therapeutics' Superior Prospects Make It A Buy - Seeking Alpha
- 2 months ago - 3 Small Biotech Stocks With The 'Big Mo' Right Now - Seeking Alpha
- 2 months ago - Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock - Business Wire
- 2 months ago - Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way - Seeking Alpha
- 2 months ago - Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock - Business Wire
- 2 months ago - Viridian Therapeutics' eye disorder treatment meets main goal in late-stage study - Reuters